UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033384
Receipt number R000038011
Scientific Title Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrier
Date of disclosure of the study information 2018/07/17
Last modified on 2021/01/13 11:46:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrier

Acronym

RRSO for BRCA1/2 mutation carrier

Scientific Title

Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrier

Scientific Title:Acronym

RRSO for BRCA1/2 mutation carrier

Region

Japan


Condition

Condition

Hereditary breast ovarian cancer syndrome

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the feasibility of risk reducing salpingo-oophorectomy for BRCA mutation carrier

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Rate of adverse event intra- or after operation

Key secondary outcomes

Rate of operation associated death
Incidence of of occult cancer


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

risk reducing sapling-oophorectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.BRCA mutant carrier
2.no prior ovarian cancer
3.wish for operation after counseling
4.no wish for pregnancy
5.over 35 years old

Key exclusion criteria

no mutation of BRCA

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Norihiro
Middle name
Last name Sugino

Organization

Yamaguchi University

Division name

Obstetrics and Gynecology

Zip code

755-8505

Address

1-1-1 Minami-kogushi Ube, Japan

TEL

0836-22-2288

Email

obgyn@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Sueoka

Organization

Yamaguchi University

Division name

Obstetrics and Gynecology

Zip code

755-8505

Address

1-1-1 Minami-kogushi Ube, Japan

TEL

0836-22-2288

Homepage URL


Email

obgyn@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University Hospital

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB Yamaguchi university hospital

Address

1-1-1 Minami-kogushi Ube, Japan

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山口大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 06 Month 27 Day

Date of IRB

2019 Year 10 Month 23 Day

Anticipated trial start date

2019 Year 11 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 13 Day

Last modified on

2021 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038011


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name